Bioextrax AB (publ) (STO:BIOEX)
3.440
+0.040 (1.18%)
Jul 16, 2025, 5:29 PM CET
Bioextrax AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2019 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2019 |
Cash & Equivalents | 12.14 | 17.27 | 13.4 | 27.53 | 8.98 | 2.05 | Upgrade |
Cash & Short-Term Investments | 12.14 | 17.27 | 13.4 | 27.53 | 8.98 | 2.05 | Upgrade |
Cash Growth | 58.17% | 28.87% | -51.33% | 206.69% | 337.54% | 250.73% | Upgrade |
Accounts Receivable | 0.08 | - | - | 0.03 | 0.12 | - | Upgrade |
Other Receivables | 0.43 | 0.73 | 0.71 | 1.27 | 0.79 | 0.17 | Upgrade |
Receivables | 0.51 | 0.73 | 0.71 | 1.3 | 0.91 | 0.17 | Upgrade |
Prepaid Expenses | 1.65 | 0.29 | 0.29 | 0.34 | 0.22 | 0.22 | Upgrade |
Other Current Assets | - | 0.91 | 0.36 | 1.23 | 1.31 | - | Upgrade |
Total Current Assets | 14.3 | 19.2 | 14.76 | 30.4 | 11.42 | 2.44 | Upgrade |
Property, Plant & Equipment | 6.53 | 6.82 | 7.76 | 7.49 | 1.22 | 0.6 | Upgrade |
Other Long-Term Assets | 2.98 | 2.98 | - | 0.03 | - | - | Upgrade |
Total Assets | 23.81 | 29 | 22.52 | 37.92 | 12.64 | 3.03 | Upgrade |
Accounts Payable | 0.52 | 1.53 | 1.33 | 3.56 | 2.22 | 0.15 | Upgrade |
Accrued Expenses | 0.92 | 0.84 | 0.44 | 0.98 | 1.04 | 0.65 | Upgrade |
Current Income Taxes Payable | 0.02 | 0.1 | 0.14 | 0.13 | 0.06 | 0.03 | Upgrade |
Current Unearned Revenue | - | - | -0.59 | 0.89 | 1.41 | - | Upgrade |
Other Current Liabilities | 0.28 | 0.47 | 0.67 | 0.6 | 0.41 | 0.55 | Upgrade |
Total Current Liabilities | 1.74 | 2.94 | 1.98 | 6.15 | 5.14 | 1.38 | Upgrade |
Total Liabilities | 1.74 | 2.94 | 1.98 | 6.15 | 5.14 | 1.38 | Upgrade |
Common Stock | 1.97 | 1.97 | 1.47 | 1.28 | 0.74 | 0.64 | Upgrade |
Additional Paid-In Capital | - | 22.32 | 9.86 | 41.73 | 15.96 | 5.78 | Upgrade |
Retained Earnings | 20.06 | 1.73 | 9.21 | -11.24 | -9.2 | -4.76 | Upgrade |
Comprehensive Income & Other | 0.05 | 0.05 | - | - | 0 | - | Upgrade |
Shareholders' Equity | 22.07 | 26.06 | 20.54 | 31.77 | 7.5 | 1.65 | Upgrade |
Total Liabilities & Equity | 23.81 | 29 | 22.52 | 37.92 | 12.64 | 3.03 | Upgrade |
Net Cash (Debt) | 12.14 | 17.27 | 13.4 | 27.53 | 8.98 | 2.05 | Upgrade |
Net Cash Growth | 58.17% | 28.87% | -51.33% | 206.69% | 337.54% | 250.73% | Upgrade |
Net Cash Per Share | 0.34 | 0.52 | 0.51 | 1.63 | 0.67 | 0.17 | Upgrade |
Filing Date Shares Outstanding | 39.12 | 39.12 | 29.23 | 25.46 | 14.75 | 12.66 | Upgrade |
Total Common Shares Outstanding | 39.12 | 39.12 | 29.23 | 25.46 | 14.75 | 12.66 | Upgrade |
Working Capital | 12.56 | 16.26 | 12.78 | 24.25 | 6.28 | 1.06 | Upgrade |
Book Value Per Share | 0.56 | 0.67 | 0.70 | 1.25 | 0.51 | 0.13 | Upgrade |
Tangible Book Value | 22.07 | 26.06 | 20.54 | 31.77 | 7.5 | 1.65 | Upgrade |
Tangible Book Value Per Share | 0.56 | 0.67 | 0.70 | 1.25 | 0.51 | 0.13 | Upgrade |
Machinery | - | 9.99 | 9.77 | 8.64 | 1.9 | 0.92 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.